arch48

EN_01498865_6906

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

TOPSHOT - An Israeli Magen David Adom medical nurse holds a vial of the Pfizer-BioNtech vaccine against the coronavirus for children, in the Israeli town of Ramat Gan near Tel Aviv, on December 23, 2021. - Israelis over the age of 60 and medical teams will be eligible for a fouth Covid vaccination, following the recommendation of an expert panelas the Jewish state struggles to contain the spread of the Omicron variant, imposing travel and other restrictions while avoiding a domestic lockdown. (Photo by JACK GUEZ / AFP)

headline arch48

created date 2021-12-23

credit JACK GUEZ/AFP/East News

source AFP

byline JACK GUEZ

original transmission reference AFP_9V74MY

weight 2,47MB

size 46cm x 31cm by 300dpi

keywords - Show

2021, 23, 60, A, ADOM, AGAINST, AGE, AN, AND, AVIV, AVOIDING, BE, BY, CHILDREN, CONTAIN, CORONAVIRUS, COVID, DAVID, DECEMBER, DOMESTIC, ELIGIBLE, EXPERT, FOLLOWING, FOR, FOUTH, GAN, GUEZ, HEALTH, HOLDS, HORIZONTAL, IMPOSING, IN, ISRAELI, ISRAELIS, JACK, JEWISH, LOCKDOWN, MAGEN, MEDICAL, NEAR, NURSE, OF, OMICRON, ON, OTHER, OVER, PANDEMIC, PANELAS, PFIZER-BIONTECH, RAMAT, RECOMMENDATION, RESTRICTIONS, SPREAD, STATE, STF, STRUGGLES, TEAMS, TEL, THE, TO, TOPSHOT, TOPSHOTS, TOWN, TRAVEL, VACCINATION, VACCINE, VACCINES, VARIANT, VIAL, VIRUS, WHILE, WILL,